Jeff Galvin, American Gene Technologies (AGT)

BioTalk with Rich Bendis

American Gene Technologies (AGT) CEO and Founder, Jeff Galvin, returns to BioTalk to share updates on their work for a potential functional cure for HIV, the growth of his company, and where they are going next.

Content Restricted

This episode can’t be played on the web in your country or region.

To listen to explicit episodes, sign in.

Stay up to date with this show

Sign in or sign up to follow shows, save episodes, and get the latest updates.

Select a country or region

Africa, Middle East, and India

Asia Pacific

Europe

Latin America and the Caribbean

The United States and Canada